benzbromarone has been researched along with Macular Degeneration in 1 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pai, HL | 1 |
| Hsieh, SM | 1 |
| Su, YS | 1 |
| Sue, XY | 1 |
| Chang, HH | 1 |
| Lin, DP | 1 |
1 other study available for benzbromarone and Macular Degeneration
| Article | Year |
|---|---|
Short-Term Hyperuricemia Leads to Structural Retinal Changes That Can be Reversed by Serum Uric Acid Lowering Agents in Mice.
Topics: Allopurinol; Angiotensin II; Animals; Benzbromarone; Hyperuricemia; Macular Degeneration; Male; Matr | 2022 |